Statins and Angiotensin-Converting Enzyme Inhibitors Are Associated With Reduced Mortality and Morbidity in Chronic Liver Disease

Basic and Clinical Pharmacology and Toxicology - United States
doi 10.1111/bcpt.12844
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Impact of Statins and Angiotensin-Converting Enzyme Inhibitors on Mortality of Subjects Hospitalised With Pneumonia

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2008English

Review: Angiotensin-Converting Enzyme Inhibitors and Coronary Heart Disease Prevention

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2007English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Angiotensin Converting Enzyme (ACE) Inhibitors

Annual Review of Pharmacology and Toxicology
ToxicologyPharmacology
1982English

Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
1992English

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease ― Propensity Score Matching Analysis ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Angioedema, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blocking Drugs

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2007English

Dosage of Angiotensin Converting Enzyme Inhibitors

BMJ
1995English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy